Novozymes A/S

Return on Assets, %

10.7

2.5

Net income margin, %

15

4.2

EBITDA margin, %

35.6

11

Debt to Equity, %

55.3

30

Intangible assets and goodwill, %

15.9

2.6

Revenue CAGR 3Y, %

8.5

10

Total Equity change 1Y, %

3.8

-0.3

Revenue Y, % chg

4.9

-7.8

P/E

35.2

25.7

P/BV

7.6

1.6

P/S

8.8

1.7

EV/S

9.2

1.8

EV/EBITDA

27.4

13

Average Analyst recommendation

Strong buy

Strong buy

Average upside forecasts, %

22.6

24.8

Forward P/E

30.3

17.1

Dividend Yield, %

0.5

1.6

Forward Dividend Yield, %

1.8

0.2

Expected dividend per share

0.9

0.1

Payout Ratio, %

0

32.2

Dividend Ex Date

2024-05-01